Al-Malki, Abdulrahman LBakkar, AshrafHuwait, Etimad ABarbour, Elie KAbulnaja, Kalid OKumosani, Taha AMoselhy, Said S2024-06-012024-06-012024-06https://doi.org/10.1016/j.biopha.2021.111960http://repository.msa.edu.eg/xmlui/handle/123456789/6005This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor-in-Chief. The journal was alerted about issues with images within Figure 3a, which appear to have multiple duplications, as detailed here: PubPeer - Strigol1/albumin/chitosan nanoparticles decrease cell viabil…. The journal requested the authors to provide an explanation to these concerns and the associated raw data, but this request was not satisfactorily fulfilled. The Editor-in-Chief assessed the case and decided to retract the article.enalbumin; chitosan nanoparticle ; apoptosis; biliary stent; cancer cell line; cell viability; drug therapy; erratum; Hep-G2 cell line; human; metabolomics; retraction noticeStrigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell lineArticlehttps://doi.org/10.1016/j.biopha.2021.111960